What question did this study set out to answer?

This review aims to examine the characteristics of SARS-CoV-2 variants and the potential of nanobodies as a therapeutic approach.

Nanobodies targeting SARS-CoV-2 variants

View Full Paper

Ask AI

Bookmark

Authors

This review summarizes nanobodies targeting SARS-CoV-2 variants, highlighting implications for COVID-19 treatments.

This review aims to examine the characteristics of SARS-CoV-2 variants and the potential of nanobodies as a therapeutic approach.
Review of SARS-CoV-2 protein constituents and their functions related to viral entry and fusion.
Analysis of the nanobodies binding to different proteins of SARS-CoV-2 variants.
Exploration of nanobody properties, including binding affinity and stability.
Identified major SARS-CoV-2 variants of concern, emphasizing Omicron's reduced sensitivity to current therapies.
Highlighted the unique advantages of nanobodies, including their small size and target-binding affinity.
Provided insights for developing novel nanobodies that may enhance therapeutic effectiveness against SARS-CoV-2.

Roy et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark